岭南生态文旅股份有限公司 公司及尹洪卫先生将积极配合中国证监会立案调查工作，并严格按照相关法律法 规的规定和监管要求及时履行信息披露义务。公司指定信息披露媒体为《证券时报》 《证券日报》《中国证券报》《上海证券报》及巨潮资讯网（www.cninfo.com.cn）， 公司相关信息均以上述指定媒体披露的公告为准。敬请广大投资者理性投资，注意投 资风险。 关于公司及原控股股东收到中国证券监督管理委员会 《立案告知书》的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 岭南生态文旅股份有限公司（以下简称"公司"）及公司原控股股东、公司现任 联席董事长兼总裁、法定代表人尹洪卫先生于近日收到中国证券监督管理委员会（以 下简称"中国证监会"）下发的《立案告知书》（编号：证监立案字 0062025016 号） （编号：证监立案字 0062025017 号）。因涉嫌信息披露违法违规，根据《中华人民 共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证监会决定对公司 和尹洪卫先生立案。 证券代码：002717 证券简称：ST 岭南 公告编号：2025-097 特此公 ...

Core Viewpoint - The resignation of Mr. Cao Chengfeng from the board of directors of Guangzhou Zhiguang Electric Co., Ltd. is due to work arrangement reasons, but he will continue to serve as the vice president and hold other positions within the company [1] Group 1 - Mr. Cao Chengfeng's resignation report was received by the board on September 5, 2025 [1] - His resignation will not affect the minimum number of directors required by law, ensuring the normal operation of the board [1] - The company expresses gratitude for Mr. Cao Chengfeng's contributions during his tenure as a director [1] Group 2 - The company will complete the director replacement process as per relevant procedures promptly [1]

Group 1 - The company held the 20th meeting of the 7th Board of Directors and the 15th meeting of the 7th Supervisory Board on September 4, 2025, where it approved the revision of the Articles of Association and related internal governance systems [1][2] - The revisions aim to enhance the corporate governance structure and promote standardized operations in accordance with relevant laws and regulations [2] - The Board agreed to revise the Articles of Association and its attachments, including the Rules of Procedure for Shareholders' Meetings and the Rules of Procedure for Board Meetings, and to establish a worker representative director [2] Group 2 - Some internal governance systems require submission for approval at the shareholders' meeting, including the management system for shares held by directors and senior management, and the remuneration management system for directors and senior management [2] - The revised systems and their specific contents are detailed in a related announcement published on the same day on the Giant Tide Information Network [2]

Core Viewpoint - The company has approved adjustments to its financing guarantee limits for its subsidiary, Chongqing Water Intelligent New Materials Technology Co., Ltd., reducing the limit from 600 million RMB to 550 million RMB, while also allowing a new guarantee for a sealing products company of up to 50 million RMB [1][6]. Summary by Sections Adjustment of Credit and Guarantee Limits - The company has adjusted the financing guarantee limit for Chongqing Water Intelligent from 600 million RMB to 550 million RMB to meet the funding needs of its newly acquired subsidiary, the sealing products company, which will seek a credit limit of up to 50 million RMB [1][6]. Basic Information of the Guaranteed Entity - Chongqing Water Intelligent was established on June 4, 2019, with a registered capital of 400.4 million RMB. Its business scope includes the research, production, and sales of polymer materials and related products [2]. Financial Performance of Chongqing Water Intelligent - As of December 31, 2024, Chongqing Water Intelligent had total assets of 869.83 million RMB, total liabilities of 521.29 million RMB, and a net profit of -22.9 million RMB. By June 30, 2025, total assets were 864.30 million RMB, with total liabilities of 524.17 million RMB and a net profit of -8.41 million RMB [3]. Acquisition of Sealing Products Company - The company plans to acquire 100% of the shares of Huarka Sealing Products (Shanghai) Co., Ltd. for 25.716 million RMB, which will become a wholly-owned subsidiary post-acquisition. The acquisition requires approval from the shareholders' meeting [4][5]. Authorization for Financing Decisions - The board of directors has proposed to authorize the legal representative or designated personnel to make financing decisions within the approved limits and to sign relevant contracts with financial institutions [5][6]. Board and Supervisory Opinions - Both the board and the supervisory committee have agreed to the adjustments in the financing guarantee limits and the new guarantee for the sealing products company, pending approval from the shareholders' meeting [6]. External Guarantee Status - As of the announcement date, the company has no overdue guarantees or potential litigation issues, with total guarantees to subsidiaries amounting to 322.05 million RMB, representing 18.12% of the latest audited net assets [6].

Group 1 - The core opinion of the legal opinion letter is that the employee stock ownership plan (ESOP) proposed by Shenzhen Kaili Biomedical Technology Co., Ltd. complies with relevant laws and regulations, including the Company Law and Securities Law [2][11][16] - The company has fulfilled the necessary legal procedures for implementing the ESOP, including soliciting employee opinions and obtaining board and supervisory board approvals [12][13][15] - The ESOP is designed to allow employees, including core management, to voluntarily participate, ensuring compliance with the principle of voluntary participation [5][14] Group 2 - The ESOP will be funded through employees' legal salaries, self-raised funds, and other legally permitted means, without the company providing financial assistance or guarantees [5][6] - The total number of shares allocated under the ESOP will not exceed 500,000 shares, representing 0.12% of the company's total equity, with a total funding amount not exceeding 7.965 million yuan [6][8] - The ESOP has a duration of 60 months and a lock-up period of 48 months, with shares vesting in four equal installments [7][8] Group 3 - The management committee will oversee the ESOP, ensuring the protection of participants' rights and compliance with market trading rules [10][11] - The ESOP will not allow forced participation and will adhere to the principle of self-determination for employees [14][15] - The company is required to continuously disclose information regarding the progress of the ESOP in accordance with regulatory requirements [16]

Core Viewpoint - The company has developed a draft for the 2025 Employee Stock Ownership Plan (ESOP) in compliance with relevant laws and regulations, aiming to enhance employee engagement and long-term development [1][2]. Group 1: Compliance and Eligibility - The company confirms that it does not fall under any prohibitive conditions outlined in the relevant guidelines, thus qualifying to implement the ESOP [1]. - The content of the ESOP aligns with the regulations set forth in the guidelines, and employee opinions were thoroughly solicited prior to its introduction [1]. Group 2: Decision-Making Process - The board of directors ensured that related directors recused themselves from voting on the ESOP, validating the legality and effectiveness of the decision-making process [2]. - The remuneration and assessment committee verified that all proposed participants meet the eligibility criteria as per the guidelines, ensuring voluntary participation without coercion [2]. Group 3: Benefits of the ESOP - The implementation of the ESOP is expected to foster a mechanism for sharing achievements and risks between talented employees and shareholders, enhancing employee ownership mentality and optimizing compensation structures [2]. - The plan aims to attract, retain, and motivate outstanding talent, thereby promoting the company's long-term stability and increasing shareholder value [2].

Core Viewpoint - The controlling shareholder and chairman of Chongqing Changjiang Modeling Materials (Group) Co., Ltd., Mr. Xiong Ying, plans to reduce his shareholding by up to 4,386,100 shares, representing no more than 3% of the company's total share capital after excluding shares in the repurchase account [1][2]. Group 1: Shareholding and Reduction Plan - Mr. Xiong holds 37,157,935 shares, accounting for 25.4152% of the company's total share capital after excluding shares in the repurchase account [1]. - The reduction will occur within three months starting from 15 trading days after the announcement, with a maximum of 1,462,030 shares to be sold through centralized bidding and 2,924,070 shares through block trading [2]. - The total number of shares to be reduced will not exceed 3% of the company's total share capital after excluding shares in the repurchase account [2]. Group 2: Commitments and Compliance - Mr. Xiong has made commitments regarding shareholding and reduction in the company's initial public offering (IPO) prospectus, ensuring that he will not transfer shares held before the IPO or allow the company to repurchase his shares [3]. - As of the announcement date, Mr. Xiong has complied with these commitments without any violations [6].

证券简称：开立医疗 证券代码：300633 深圳开立生物医疗科技股份有限公司 （草案） 声明 本公司及全体董事保证本员工持股计划草案及其摘要不存在虚假记载、误 导性陈述或重大遗漏，并对其真实性、准确性、完整性承担个别和连带的法律 责任。 风险提示 否获得公司股东大会批准，存在不确定性； 在不确定性； 完成实施，存在不确定性； 资金较低，则本员工持股计划存在不能成立的风险；若员工认购资金不足，则 本员工持股计划存在低于预计规模的风险； 动，投资者对此应有充分准备。 意投资风险。 特别提示 施员工持股计划试点的指导意见》《深圳证券交易所上市公司自律监管指引第 及《公司章程》的规定制定。 派、强行分配等强制员工参加本员工持股计划的情形。 独立董事）、高级管理人员及核心管理人员。拟参与本员工持股计划的员工总 人数不超过 7 人，其中董事（不含独立董事）、高级管理人员 3 人，其他员工 不超过 4 人，具体参与人数以实际自愿参加的员工及其参与情况为准。 股票。本持股计划经公司股东大会审议通过后，将通过非交易过户等法律法规 允许的方式获得公司回购专用证券账户所持有的公司股份。 持股计划董事会决议日至标的股票过户至本持股计 ...

Core Viewpoint - Shenzhen Sunlord Electronics Co., Ltd. held its first meeting of the fifth employee stock ownership plan on September 4, 2025, where key resolutions were passed regarding the establishment and management of the plan [1][2]. Group 1: Establishment of Management Committee - The meeting approved the establishment of the management committee for the fifth employee stock ownership plan, which will oversee the daily management of the plan [1][3]. - The management committee consists of five members, including one chairperson, with a term that aligns with the duration of the employee stock ownership plan [1][3]. Group 2: Election of Committee Members - The meeting elected five individuals to the management committee: Mr. Shi Hongyang, Mr. Li Youyun, Mr. Li Yu, Mr. Xu Jia, and Ms. Ren Yi, with their terms also aligning with the plan's duration [2][3]. - Notably, Mr. Shi Hongyang, Mr. Li Youyun, and Mr. Li Yu hold 30% of the shares in a company that owns 6.88% of Sunlord's total shares, but they do not have any related party relationships with other major shareholders or executives [2][3]. Group 3: Authorization of Management Committee - The meeting authorized the management committee to handle various matters related to the employee stock ownership plan, including convening meetings and supervising daily management [3][5]. - Specific responsibilities include representing all holders in exercising shareholder rights, managing profit distribution, and handling inheritance registration of stock ownership [5][6].

Group 1 - The core issue involves multiple lawsuits filed by Murata Manufacturing Co., Ltd. against the company for alleged patent infringement, with some cases already withdrawn and others still under review [1][2][3] - The company has received notifications regarding the lawsuits, including a civil complaint and a response notice from the Shanghai Intellectual Property Court [1] - As of the latest announcement, the plaintiff has withdrawn two cases, while three cases are still in the trial phase [2][3] Group 2 - The company does not recognize the claims made by the plaintiff and intends to actively respond to the lawsuits, emphasizing its commitment to intellectual property rights and innovation [3] - The financial impact of the ongoing lawsuits on the company's current and future profits remains uncertain, pending court decisions [3] - The company will closely monitor the situation and take necessary legal measures to protect its rights and interests, ensuring timely updates on the progress of the cases [3]